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Primary neuronProtein misfolding and proteostasis decline is a common feature of many neurodegenerative dis-
eases. However, modeling the complexity of proteostasis and the global cellular consequences of
its disruption is a challenge, particularly in live neurons. Although conventional approaches, based
on population measures and single ‘‘snapshots’’, can identify cellular changes during neurodegener-
ation, they fail to determine if these cellular events drive cell death or act as adaptive responses.
Alternatively, a ‘‘systems’’ cell biology approach known as longitudinal survival analysis enables
single neurons to be followed over the course of neurodegeneration. By capturing the dynamics
of misfolded proteins and the multiple cellular events that occur along the way, the relationship
of these events to each other and their importance and role during cell death can be determined.
Quantitative models of proteostasis dysfunction may yield unique insight and novel therapeutic
strategies for neurodegenerative disease.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V.
D license.1. Introduction
Proteostasis involves a dynamic and highly integrated network
of millions of proteins. Multiple cellular processes, intricately inte-
grated, ensure homeostasis [1]. Breakdown of the network leads to
cellular dysfunction and cell death [2]. Much effort has focused on
determining if disruption of proteostasis is causally linked to
neurodegenerative diseases, including Parkinson’s disease (PD),
Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and
Huntington’s disease (HD) [3]. Neurodegenerative diseases
normally present late in life with different symptoms, but they
all involve deposits of insoluble protein in the brain [4]. At a molec-
ular level, these diseases, also termed proteinopathies, are caused
by distinct proteins, but they all undergo protein misfolding, show
similarities in the multiple cellular pathways that are disrupted,
and eventually lead to neuronal death [5]. Despite this conver-
gence in cellular consequences, strategies to enhance proteostasis
have not been translated into therapies.
Recently, considerable interest has been directed towards
modeling disease to capture early changes and the temporal andspatial progression of dysfunction and adaptive responses, and
ultimately, to relate these events to cell death [6,7]. Models that
more faithfully recapitulate the complexity of the disease may
improve the success rate of biomedical drugs [8]. Here, we will
discuss the properties of proteostasis and neurodegeneration that
make them difﬁcult to model and describe a ‘‘systems’’ biology
approach to model their complexity.
1.1. Modeling the complexity of proteostasis in single cells
Given the complexity of proteostasis, determining how proteins
misfold and why cells fail to handle them is a challenge. The pres-
ence of misfolded proteins is probably a consequence of opposing
pressures on structural stability and functional ﬂexibility [9]. As
the abundance of a protein imposes a stronger evolutionary pres-
sure on its coding sequence than its actual function [10], the cost
of protein misfolding to the fate of the cell may be high. In a cell,
the accumulation of misfolded protein reﬂects a decline in the cell’s
ability to maintain proteome stability. In some models, only a 4 C
increase is enough to destabilize at least 16% of the proteome [11],
suggesting that even small perturbations can greatly affect the pro-
teome. Common causes of neurodegenerative disease favor protein
misfolding, including mutations in disease-associated proteins and
exposure to environmental stimuli, such as oxidative stress [12,13].
Fig. 1. The different roles of cellular events during neurodegeneration. Schematic
shows how, during the course of neurodegeneration, cellular changes may be
pathogenic. Alternatively, some changes may be incidental events, while others
may be adaptive responses that occur to cope with the pathological events within
the cell. As these events may occur in parallel and correlate with cell death,
distinguishing their roles can be difﬁcult.
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ics of proteins is based on in vitro biochemical approaches and in
silico studies [14,15]. These methods have provided a wealth of
knowledge and shaped a number of concepts surrounding protein
folding, including the role for intermediate species [16] and folding
energy landscapes [17,18]. These studies often focus on proteins
that fold rapidly and rarely misfold and aggregate [16]. However,
in neurodegenerative diseases, conformational instability and
aggregation prevail [19] and the folding landscapes and intermedi-
ate species of disease-related misfolded proteins may require a dif-
ferent understanding. A remarkable number of disease-associated
proteins are intrinsically unstructured and exhibit conformational
promiscuity. Although this allows for multitasking, mutations that
disrupt function may lead to collapse of a network of cellular pro-
cesses [20].
In vitro biochemical and in silico approaches also lack the cellu-
lar milieu that is essential for protein dynamics. Post-translational
modiﬁcations and intracellular crowding of macromolecules,
including chaperones, affect protein interactions [21] that, in turn,
inﬂuence the folding rates [22], stability, and function of proteins
[23–25]. Ideally, physiologically relevant measurements of proteo-
stasis should be carried out in live cells. There is a growing interest
in modeling biological systems through a ‘‘middle-out’’ approach,
in which the cell is the basic unit of the system and contains spa-
tiotemporal information at multiple levels [26]. Information quan-
tiﬁed at each level of the cell can be used to build predictive
models that measure the effects of misfolded proteins on the cell.
At a genetic level, modiﬁers can inﬂuence the cell’s capacity to
cope with misfolded proteins. For example, in an ALS model, tem-
perature-sensitive mutations in various unrelated genes enhance
misfolding of superoxide dismutase 1 (SOD1) [12]. At a molecular
level, misfolded proteins can be measured to determine how pro-
cesses, such as transcription, translation, folding, trafﬁcking, and
degradation affect their dynamics [1]. Conformational sensors
can be used to measure rates of misfolding [27] or the effects of
protein misfolding on proteome stability [28]. Reporters can also
provide readouts for the activation of adaptive strategies, including
the heat shock and unfolded protein responses [29], or mecha-
nisms that target misfolded proteins for degradation [30]. These
pathways are critical for modulating protein misfolding and toxic-
ity in multiple models of neurodegeneration, such as ALS, PD, and
HD [31–34]. Molecular complexes and organelle dynamics can also
be measured in a cell, providing insight into the multiple cell pro-
cesses that coincide with the build-up of misfolded proteins,
including mitochondrial dysfunction, aberrant trafﬁcking, synapse
dysfunction and altered signaling [35].
Using the cell as the basic unit of the system to measure the im-
pact of protein misfolding requires the simultaneous capture of
both the dynamics of the misfolded protein and the stochastic cel-
lular changes that result. In addition to identifying how misfolded
proteins cause cell dysfunction, it is also critical to determine
which cellular events drive neurodegeneration. Although some cel-
lular events may be harmful, some changes may be incidental or
even adaptive responses to more subtle maladaptive changes else-
where in the cell.
1.2. Separating pathogenic events from adaptive strategies
Neurodegeneration is progressive and may occur along a single
pathway or multiple distinct cellular pathways that arise from the
same initial insult [36]. In addition, the roles of the cellular events
during neurodegeneration may differ. Some may reﬂect true path-
ogenic insults, whereas others may be beneﬁcial, adaptive strate-
gies that are up-regulated to cope with the build-up of misfolded
proteins [29] (Fig. 1). The extent to which a true coping response
is activated is dependent on the pathogenic event that incites it.Therefore, pathogenic events and coping responses will occur in
parallel, and both will correlate with cell death, making separating
their roles during the disease process very difﬁcult.
For example, amyloid-like structures form as a common feature
of many neurodegenerative diseases [3]. Early reports implicated
amyloid deposits as the toxic species because they were consis-
tently found in the brains of deceased patients. At the time, this
seemed to be a reasonable conclusion. The distribution of various
pathologies provides temporal resolution of the activities of dis-
ease-related proteins within those pathological changes. However,
any given sample represents only a single ‘‘snapshot’’ in the life of
the protein. In addition, conclusions based on pathological events
from postmortem tissue might represent a bias of ascertainment:
the tissue comes from patients who have already lost many of
the speciﬁc neurons affected by the disease. Furthermore, although
amyloid deposits were found in many deceased patients, many
non-toxic proteins also form amyloid structures [37]. Mounting
evidence suggests that amyloid structures sequester toxic mis-
folded conformers and principally serve as a coping response by
the cell [38–40]. This adaptive response is becoming an increas-
ingly common theme in the study of the major neurodegenerative
disorders [41].
The unfolded protein response might also be activated in re-
sponse to rising levels of misfolded protein in the cell [42]. It is
mediated, in part, by phosphorylation of the a-subunit of eukary-
otic translation initiation factor (elf2a-P), which is found in greater
amounts in AD and PD patients than in non-patients and causes the
transient shutdown of protein translation, including that of the
misfolded protein [43,44]. Protein translation requires a great deal
of energy [45], and repressing translation allows reallocation of
molecular chaperones to detect and respond to protein misfolding
elsewhere in the cell [46] and to promote the selective translation
of stress-response genes [47]. However, repressing translation for
too long can be detrimental to the cell. Accumulation of the
misfolded prion protein is associated with synaptic dysfunction,
neurodegeneration and persistent translational repression of
global protein synthesis by elf2a-P. Interestingly, irrespective of
the presence of the misfolded prion protein, stimulating protein
translation preserved synapses and rescued neurodegeneration
[48]. It remains unknown if restoring translation prevents neuro-
degeneration in the long term, even if the initial insult, misfolded
prion protein accumulation, is not directly addressed.
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ply incidental requires a method that (a) measures levels of mis-
folded proteins and cellular responses simultaneously in the
same cell and (b) links these events to when the cell dies. In addi-
tion to determining the role of cellular events, longitudinally track-
ing cells captures whether an adaptive response is time dependent
(e.g., whether the beneﬁcial effect declines or even becomes harm-
ful to the cell when chronically activated).
1.3. Harnessing cell-to-cell variation
The stochastic nature of pathological events often confounds
the investigation of proteostasis dysfunction in neurodegeneration.
Even within uniform cell populations, stochastic cell-to-cell varia-
tion results from intrinsic ﬂuctuations in the levels of gene tran-
scription and translation [49], or extrinsic ﬂuctuations, such as
variations in numbers of RNA polymerase or ribosomes [50]. The
biological consequences of cellular variation are not clear. Cell-
to-cell variation in protein expression is proportional to protein
abundance [51] and protein stability [52] and is inﬂuenced by tran-
scriptional bursting [53]. Variation may have evolved to promote
beneﬁcial diversity [54] and enable the evolution of stable pheno-
typic switches [55]. The noise in dynamic populations of proteins
ultimately leads to the coexistence of different gene-regulatory
network states and signaling systems [56,57].
Interestingly, the level of protein variation may be reﬂected in
the function of the protein. For example, levels of non-essential
stress-related genes vary more than predicted, potentially reﬂect-
ing the beneﬁt of variation in this class of genes. In contrast, essen-
tial genes involved in protein degradation and synthesis vary less,
potentially reﬂecting their need to be more precise [51]. Alterna-
tively, cell variation may have to be overcome to achieve robust
function. Cell variation increases with age and is further exacer-
bated by oxidative stress [58], two common risk factors for
neurodegeneration.
Studying how cells control, tolerate, and harness variability is a
challenge. Conventional cell-based approaches often average mea-
surements over populations, whereby cell-to-cell variability is
treated as a technical rather than biological variation. As such,
proper statistical treatment of variability reduces the sensitivity
and power to detect differences in mean responses between popu-
lations of cells. Determining the variability between cells with re-
spect to a phenotypic characteristic requires quantitative analysis
in a large number of cells over long periods of time [51]. Develop-
ing experimental methods that quantify cell-to-cell variation and
relate it to biology at a single-cell level would enable the source
and dynamics of variation to be harnessed, and would enhance
the power and sensitivity to investigate the role of cellular states
during neurodegeneration.
1.4. Why is protein misfolding so common in neurons?
Accumulation of misfolded proteins indicates a failure in the
network of processes that recognize, re-fold and degrade misfolded
proteins. Why neurons are particularly susceptible to this failure is
unclear. Although common to neurons, deﬁciencies in proteostasis
are also observed in other cell types leading to diseases, such as
type II diabetes, cancer, cystic ﬁbrosis, cardiovascular disease,
and multiple myeloma [59], suggesting similarities in the compo-
sition of the proteostasis machinery and adaptive responses across
different cell types. However, in neurons, components of the prote-
ostasis machinery – including autophagy [60] and the heat shock
response [61,62] – are regulated differently. Differences in proteo-
stasis capacity may also extend to different subtypes of neurons.
Disease-associated proteins are often expressed in multiple cell
types, and often at much higher concentrations than in the speciﬁcneuron subtype that is preferentially affected in the disease
[63,64]. Also within neurons, changes in synaptic strength are reg-
ulated by local control of degradation [65]. Controlling proteostasis
at a subcellular level requires directional transport of mRNA and
translational machinery to and from the soma to distal dendrites
[65], potentially increasing sensitivity to proteostasis dysfunction.
Neurons also inﬂuence misfolding by non-cell-autonomous
mechanisms. In Caenorhabditis elegans, modulating signaling in
neurons inﬂuences activation of the heat shock response [66], pro-
tein aggregation, and toxicity in neighboring somatic cells [67,68].
Neurons are also post-mitotic cells, so misfolded proteins may
accumulate due to an age-dependent decline in the proteostasis
machinery and quality control mechanisms [59,69]. In transgenic
models, accumulation of misfolded proteins is linked to the age
of the animal [70], which could explain why most neurodegenera-
tive diseases have a late onset and the aging process itself acts as a
major risk factor [71]. Given the unique proteostasis characteristics
of neurons, establishing models in primary neurons may be essen-
tial to investigate why and how misfolded proteins accumulate
during neurodegeneration.
To faithfully study proteostasis in live neurons, we need a
longitudinal approach that captures the dynamics of misfolded
proteins and their effects on multiple cellular processes. Cell-to-
cell variation needs to be harnessed to increase the power and sen-
sitivity in determining which events drive pathogenesis, and which
are incidental or adaptive. This will be critical for determining the
inﬂuence of proteostasis decline during neurodegeneration and for
developing therapeutic strategies. A systems cell analysis
approach, known as longitudinal survival analysis, may ﬁll this
gap.
2. Systems approaches in cell-based models: systems cell
biology
Systems biology approaches that combine experimental and
mathematical tools are increasingly attractive for capturing the
complexity of disease [72,73]. In conventional approaches to study
mechanisms of dysfunction, a single cellular feature or biological
process is perturbed, while other variables are kept constant, and
a phenotypic outcome is observed. There are at least two problems
with this approach. Efforts to keep other variables constant often
involve highly reductionist systems or constraints that reduce
the physiological relevance of the ﬁndings. Even then, the relevant
biological network is often not fully understood, so critical vari-
ables may remain uncontrolled, confounding the interpretation of
the results.
Alternatively, systems approaches address biological complexity
by gleaning insights from direct measurements and sophisticated
mathematical analysis of many components of biological networks,
without overly constraining or oversimplifying them experimen-
tally. Modeling cellular systems as a network enables multiple cel-
lular features or transient cell states to be observed simultaneously.
Single phenotypic endpoints are replaced by temporal phenotypic
proﬁles [74], enabling genetic or environment perturbations to be
reﬂected as changes in network components, their interactions
and overall network structure. Modeling disease as a perturbation
of cellular networks is proving to be a successful strategy for dis-
secting disease mechanisms and developing new therapeutic strat-
egies [75,76]. Unlike conventional single-target strategies, multi-
target drug strategies identiﬁed by network-based analyses favor
therapies that target less essential components of the network,
thereby offsetting the potential for side effects [77]. Also, systems
approaches might be particularly well-suited for phenotypic
screens, which returned to popularity after it was discovered that
they are a greater source for FDA-approved ﬁrst-in-class drugs than
more conventional target-focused screens [78].
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tems, where the cell is the basic unit of the system [26], informa-
tion can be collected at multiple scales, including transcription,
translation, complexes, organelles and metabolism. In addition,
large numbers of individual cells lead to cell–cell and cell–environ-
ment interactions that provide information on homeostasis or dys-
regulation of the cellular community [26]. Unlike traditional ‘‘top-
down’’ or ‘‘bottom-up’’ systems biology approaches, ‘‘middle-out’’
approaches overcome cell-to-cell variation, as information is ex-
tracted from single cells. A big challenge for systems cellular biol-
ogy is to develop methods that identify and probe network
components and quantify their dynamic interactions after multiple
perturbations [6].
3. Longitudinal survival analysis: a systems cell biology analysis
approach
Longitudinal survival analysis consists of high-throughput and
high-content analysis platforms that enable single cells and their
individual characteristics to be longitudinally tracked and linked
to when the cell dies [7,79–81]. In parallel, the development of
powerful survival statistical tools enables predictive temporal rela-
tionships between extracted cellular features and a speciﬁed end-
point to be quantiﬁed (e.g., determining if a cell with high levels of
a misfolded protein is likely to die sooner than a cell with lower
levels). Cell death is an obvious endpoint for studying neurodegen-
eration, but the event could be anything that is observed in a cell,
including formation of a protein inclusion, synaptic loss, mitochon-
drial alterations, changes in neurite structure or activation of a spe-
ciﬁc pathway. As the cell contains information at multiple levels,
once a speciﬁed endpoint is chosen, cause-effect relationships
across multiple cellular features and the endpoint can be deter-
mined simultaneously, enabling the establishment of a cellular
systems model. Perturbations of the cellular system by disease-
causing mutations or extrinsic factors (including environmental
stress or therapeutic agents) are reﬂected by changes in the impor-
tance and roles of the predictive relationships between cellular fea-
tures and the endpoint. The power, sensitivity, and novelty of
longitudinal survival analysis emerges from the integration of
physiologically relevant neuronal models of disease, high-through-
put imaging and high-content analysis platforms, and powerful
statistical survival models.
3.1. Physiologically relevant cell models of disease
A predictive, sensitive, and robust model of neurodegeneration
must recapitulate key features of the disease, such as neurite loss,
protein aggregation, and neuron death. Establishing models using
single cells provides information at multiple scales with signiﬁcant
control and rigor. Although harder and more expensive to handle,
the focus has shifted from immortalized cell lines to the use of pri-
mary neurons, which are more physiologically relevant [82]. With
the discovery of induced pluripotent stem cells (iPSCs) [83,84],
multiple subtypes of human primary neurons that display cell-
type-speciﬁc characteristics can be cultured at will [85–87]. More
excitingly, subtypes of neurons can be differentiated from iPSCs
derived from patients with neurodegenerative disease. Many stud-
ies have already demonstrated that these cells recapitulate fea-
tures of the disease [88–91]. iPSC technology enables the
establishment of human models, even of the sporadic disease. It
also allows us to understand the extent to which disruption of pro-
teostasis is a common thread even in cases where the cause of neu-
rodegeneration is not known precisely.
The use of longitudinal survival analysis is not limited to disso-
ciated primary neuron cultures. Organotypic cultures that retain
features of multicellular brain tissue, including 3D microculturesystems, brain slices or simple organisms, could be used and would
provide signiﬁcant information on non-cell-autonomous mecha-
nisms that may inﬂuence proteostasis [67,68]. In vivo imaging by
two-photon confocal microscopy has already enabled the longitu-
dinal tracking of cellular events, including aggregation, degrada-
tion, and localization of misfolded proteins in models of
neurodegeneration [92–94]. However, more elaborate models re-
quire more effort to set up and maintain. Furthermore, their
throughput is much lower, reducing the sensitivity and predictive
power in determining cause-effect relationships.
3.2. Custom-built automated robotic microscope systems
Unlike conventional cellular perturbation studies that extract
information at a single point, longitudinal survival analysis tracks
individual cells to capture spatial and temporal changes within
the cells (Fig. 2). Individual neurons studied using longitudinal sur-
vival analysis can be tracked by customized automated robotic
microscope systems built in our lab [7,80,81], combined with pri-
mary neuron cultures transfected with ﬂuorescent reporters. The
low transfection efﬁciency often associated with primary neurons
is optimal for longitudinal survival analysis because it makes it
easier to distinguish and therefore automatically identify, track,
and characterize each neuron independently. Our microscope plat-
forms and in-house software acquire highly focused epiﬂuores-
cence images in an automated and high-throughput manner,
enabling tens of thousands of cells to be imaged and tracked
[81]. One of the unique features of this system is that a ﬁduciary
mark is taken of each plate at the start of the experiment, enabling
the plate to be realigned to exactly the same location even after the
plate has been removed and then replaced onto the microscope [7].
This is essential if the same ﬁeld of individual cells is to be followed
for days, weeks, or months.
3.3. Deﬁning cellular proﬁles by ﬂuorescent reporters
As the automated microscope images the same neuron repeat-
edly during its lifetime, the gradual and stochastic cellular events
that occur during proteostasis dysfunction and neurodegeneration
are also imaged [7]. Capturing these cellular events in single cells
and then recording when or if the cell dies are essential if the role
of an event during cell death is to be determined [7,80,95]. As ﬂuo-
rescent proteins (FPs) are expressed diffusely throughout the cell,
loss of ﬂuorescence is a read out for changes in morphology, such
as neurite loss and cell death, two common features of neurode-
generation (Fig. 2A) [79]. Fluorescence in a cell also indicates the
location of a cell relative to others in the ﬁeld. This could be critical
for determining the importance of non-cell-autonomous mecha-
nisms of neurodegeneration, such as whether glia have a protective
or destructive role [96,97] or if intercellular transfer of pathogenic
proteins is important for disease progression [98]. Loss of synapses
is another common feature of neurodegenerative diseases [99].
Numbers of synapses per neuron can be assessed by transfection
of ﬂuorescently tagged marker proteins of synapses, such as synap-
sin-1 or postsynaptic density protein 95 (PSD95). As individual
cells are tracked longitudinally, synapse formation, maintenance
and loss can be quantiﬁed during the cell’s life, and the signiﬁcance
of these processes during neurodegeneration can be determined.
Although FPs can be attached to any protein, caution must be
exercised to ensure that the FP and its location on the protein does
not signiﬁcantly alter its physiological function, including its sub-
cellular localization and turnover in the cell [100]. However, by
attaching a FP to a disease-associated protein, longitudinal survival
analysis can be used to capture the dynamics of the protein and
determine the role of its transient states, in real time, during
neurodegeneration. This approach was used to investigate how
Fig. 2. Longitudinal survival analysis. (A) Representative time-lapse image panel of primary rat neurons transfected 6 DIV with mRFP, which is diffusely expressed
throughout the neuron. Images of the same neuron were taken once every 12–24 h. RFP expression indicates neurite retraction (arrow head) and cell death (arrow). Bar is
10 lm. (B) Each individual neuron is tracked and custom-analysis programs extract spatial and temporal ﬂuorescence data for their time of death, along with multiple cellular
features. (C) Data from thousands of neurons incorporated into a multivariate regression survival model. For each cellular event, its role (deﬁned in terms of Hazard Ratio (HR)
below or above 1) and importance (magnitude of the HR) during neurodegeneration is calculated (IB is inclusion body).
Fig. 3. A ﬂuorescence reporter measures ARE activity in live neurons. Representa-
tive images of rat neurons transfected with Venus (to mark neuronal morphology)
and ARE-Apple, a reporter of ARE activation. (A) Cells overexpressing Nrf2 have a
strong activation of the ARE-Apple reporter compared to cells expressing the
control vector (B). (C) Cells transfected with the PD-associated protein a-synuclein
show an increase in ﬂuorescence of the reporter, indicating that ARE has been
activated by stress caused by misfolded proteins. Bar is 10 lm.
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affect cell survival in models of HD, PD and ALS [32,79,101]. Photo-
switchable FPs, such as Dendra2 or Eos2, can also be used to follow
a stable intracellular population of proteins, enabling measures of
protein turnover within single cells. Analysis of GFP-degradation
rates in single cells indicates that they are independent of initial
intensity of GFP ﬂuorescence [102]; however, it remains unknown
whether this is true for disease-associated misfolded proteins.
Furthermore, it is unknown how rates of decay of disease-related
proteins predict the fate of the cell.
FPs can also act as sensors to quantify conformational changes
and rates of misfolding in proteins. Such sensors, in which protein
tetracysteine motifs bind the biarsenical dyes ReAsH and FlAsH
with high speciﬁcity, have been used to measure conformational
changes of mutant Htt in single cells [27]. FPs attached to destabi-
lized proteins that misfold in the presence of disease-associated
proteins, such as polyglutamine (polyQ) expanded Htt, or small-
molecule inhibitors of proteostasis. Their propensity to misfold is
a measure of global consequences to overall proteome stability
and can potentially predict widespread cellular dysfunction [28].
FPs can also be used to quantify the size, morphology or func-
tion of cellular organelles. For example, longitudinal survival anal-
ysis was used to infer the importance of mitochondrial
fragmentation during a-synuclein-mediated toxicity [103]. Expres-
sion of FPs can be put under the control of promoter regions of
speciﬁc genes and used to report and quantify the activity of spe-
ciﬁc pathways. A reporter gene comprising of a gene encoding a FP
under the control of the antioxidant response element (ARE) is able
to quantify the cell’s response to stress. NF-E2-related factor-2
(Nrf2) binds to the ARE in multiple genes, activating cytoprotective
mechanisms against an array of cellular stresses including mis-
folded proteins, such as the PD-associated protein a-synuclein
[104–106] (Fig. 3).
Finally, photostable and bright ﬂuorophores that span the
breadth of the visible and infra-red spectrum [107] enable sufﬁ-
cient spectral separation so that multiple channels can be imaged
simultaneously without bleed-through. This allows multiple ﬂuo-
rescent reporters to be co-transfected and followed in each cell.
For example, changes in multiple cellular pathways or processes
can be captured simultaneously along with changes in localization,
aggregation or degradation of the disease-associated protein.
Custom analysis programs can then extract spatial and temporal
ﬂuorescence data for multiple cellular features, providing each
individual neuron with a multiparametric ﬂuorescence proﬁle[81]. Most crucially, each individual cell proﬁle is linked to the ulti-
mate fate of the cell, enabling statistical models to determine the
roles of changes in cellular processes or dynamics of the disease-
associated protein during neurodegeneration.
4. Applying statistical survival tools to single cell analysis
Once individual cells have been longitudinally tracked and im-
aged, spatial and temporal ﬂuorescence data are extracted from
the multiparametric ﬂuorescence proﬁles of individual neurons
(Fig. 2A). Extracted data include information on cellular variables
that can be discrete (e.g., the presence or absence of a protein aggre-
gate) or continuous (e.g., the amount of a-synuclein expressed in
the cell). Statistical tools can be used to model the relationship be-
tween multiple cellular features, and their relationship to a deﬁned
endpoint, such as death. A distinguishing feature of survival analy-
sis is that it accounts for individuals that may not reach the deﬁned
endpoint (e.g., cells that are still alive at the end of the experiment)
by censoring them (Fig. 2B). The Kaplan–Meier method and Cox
proportional hazard analysis are commonly used in clinical medi-
cine to investigate the role of cellular variables on survival
[108,109]. Cox analysis can be used to quantify the difference in
hazard, also known as a hazard ratio, between two or more groups
(Fig. 2C). For example, cells expressing a disease-associated
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4.1. Determining predictive relationships between cell events and an
endpoint
In contrast to linear or logistic regression analysis, survival
regression models can be used to predict if a cellular event predicts
a speciﬁc end point (e.g., does the cellular event increase or de-
crease the chance of death?), and if it does, what is that magnitude
of this effect (e.g., how much does the presence of the cellular
event increase the risk of death) [110]. Often cellular features are
stochastic events, with the same event occurring in different cells
at different times. Irrespective of whether a change is pathogenic
or a coping response, it would be expected to appear speciﬁcally
after disease has begun and would track the disease severity pretty
closely. Conventional cell models are often based on population or
gross correlations that lack the resolving power to tell the two
apart. To separate the roles, you need to identify an event that is
unequivocally pathogenic (e.g., cell death) and then measure the
role of putative contributing factors by determining the extent to
which their appearance accelerates or retards the unequivocal
pathogenic event. Those that accelerate are predicted to be patho-
genic; those that retard are likely coping responses. Thus, the
resolving power depends on the ability to measure the time that
elapsed between two key events in the same cell. Although deﬁn-
ing predictive relationships is a powerful approach, we are still
deﬁning statistical associations and so cannot assume certainty
for the role of the cellular events on the endpoint. It still remains
possible that the cellular event is inextricably linked but not di-
rectly involved in the pathway that accelerates or retards the
endpoint.
For example, pathological analyses of HD patients demon-
strated that the abnormal desposition of mutant huntingtin (Htt)
protein into inclusion bodies (IBs) grossly correlated with disease
progression [111]. To determine if these deposits are pathogenic,
incidental or represent a coping mechanism to handle the more
toxic species of mutant Htt, individual neurons expressing mutant
Htt were followed throughout their lives by longitudinal survival
analysis. Unlike conventional methods, survival analysis can ac-
count for intercellular variability to precisely identify which cells
form an IB and when, providing increased sensitivity and power
that enables determination of the relationship between IB forma-
tion and neurotoxicity. Surprisingly, in neurons expressing mutant
Htt, those that formed IBs had a lower risk of death then those
without [79].
Up-regulating the degradation of misfolded proteins reduces
toxicity in many models of neurodegeneration [32,33]; however,
improved cell survival may be at the expense of synaptic function
[112]. Mutations in leucine-rich-repeat kinase 2 (LRRK2), a com-
mon genetic cause of PD, causes age-dependent biphasic changes
in autophagy activity [113]. It remains unclear what role autopha-
gic activity plays during neurodegeneration. However, it is possible
that its role may be time dependent, with its relationship to death
weakening or strengthening with time. Longitudinal survival anal-
ysis follows neurons throughout their life, enabling the presence
and magnitude of time-dependent effects to be quantiﬁed [114].
4.2. Controlling for confounding and competing cell events
An advantage of longitudinal survival analysis is the ability to
control for critical variables that, if unconsidered, can conceal the
true effect of another cellular event on death [115]. For example,
if we want to determine how levels of Htt affect the risk of death
of neurons we need to control for IB formation. Cells with IBs have
a lower risk of death; however, increased levels of mutant Httgreatly enhance the chance of IB formation [79], making IBs a con-
founding effect in determining the relationship between Htt levels
and neurotoxicity. Survival analysis can account for confounding
effects, either by stratifying by this cellular feature or by including
it as an independent variable in the survival model. In a model of
HD, when IB formation was stratiﬁed, Htt levels were found to
have a positive relationship with neuron death that saturated at
longer polyQ lengths [116].
Defects in protein degradation pathways are linked to a number
of neurodegenerative disorders [117]. Many conventional ap-
proaches that calculate degradation rates of misfolded proteins
disrupt the cell for biochemical analysis and use results from the
whole cell population as a read out [100]. In neurodegeneration,
many disease proteins lead to increased rates of death and forma-
tion of aggregates (which poorly solubilize); this has an overall
competitive effect, confounding population-based measurements
of protein degradation rates. Alternatively, ﬂuorescence from
photoswitchable FPs attached to misfolded proteins can be ana-
lyzed with longitudinal survival analysis to capture the spatial
and temporal dynamics of a stable intracellular population of pro-
teins. As cell death and IB formation can be captured simulta-
neously, these competing effects are included and accounted for
in the analysis to determine the degradation rate of the misfolded
protein [118,119].4.3. Constructing complex survival models
Imaging and tracking multiple cellular features simultaneously
in a single neuron enables more than one cell feature to be in-
cluded in the survival model. In this way, the effect of individual
cellular features on neurodegeneration can be quantiﬁed relative
to each other (i.e., can be used to determine which cellular feature
plays a more important role during neurodegeneration). For exam-
ple, in a model of ALS, survival analysis identiﬁed mislocalization
and overall levels of TDP43 as positive predictors of death during
neurodegeneration. However, it was only when both were in-
cluded in the survival model simultaneously that mislocalization
was found to be the more important predictor for toxicity than lev-
els of TDP43 [101].
As the number of cellular events that are being tracked in-
creases, modeling the relationships between cellular events be-
comes increasingly challenging. The relationship between
variables may interact in a complex non-linear manner. Statistical
tools, such as penalized splines [120], enable a more ﬂexible rela-
tionship to be modeled between the variable and death, with both
the linear and non-linear terms in the relationship being quanti-
ﬁed. Alternatively, more complex survival models, based on Bayes-
ian statistics [121], can be used to model parameter uncertainty by
using prior probability distributions [122]. Such approaches can
enhance the predictive power of the relationships between cellular
features and neurodegeneration. The development of survival
models to incorporate multiple cellular features, and the ability
to model their complex relationships with each other and a speci-
ﬁed endpoint, such as death, enables the emergence of a system
cell biology approach to analyze proteostasis dysfunction during
neurodegeneration.5. Conclusions
Dysfunctions in proteostasis give rise to pathogenic and adap-
tive responses that occur in parallel and correlate with cellular de-
cline. Features of these cellular responses such as their stochastic
nature, sometimes confounding relationship to other responses,
time-dependency or subtlety can obscure efforts to determine
their true role during neurodegeneration. Conventional models
G. Skibinski, S. Finkbeiner / FEBS Letters 587 (2013) 1139–1146 1145that rely on population-based or qualitative measures sacriﬁce
resolving power, precision, and possibly physiological relevance
for simplicity. Alternatively, a systems cell biology analysis ap-
proach, such as longitudinal survival analysis, enables the identiﬁ-
cation, tracking and quantiﬁcation of cellular components,
including the disease protein itself and changes in cellular pro-
cesses. Through statistical modeling, the interaction and relation-
ship of these components to each other, and to the fate of the
cell, can be determined. As more cellular components are tracked,
the model becomes more complex, until a sensitive network of cel-
lular events emerges that can reveal more subtle yet signiﬁcant
predictive events during neurodegeneration. Monitoring network
differences in the presence or absence of perturbations may reveal
important insight into the underlying mechanisms and the discov-
ery of potential genetic modiﬁers. A transition towards a systems
cell biology approach could also enable the development of combi-
natorial therapies that target less essential parts of the cellular net-
work to increase efﬁcacy and decrease side effects [6].
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